Natural hydrogen exploration gains traction as Benton Resources Inc. stakes six Newfoundland projects with Metals Creek Resources Corp.
Canamera Energy Metals Corp. tests third ionic clay REE asset as Brazil strategy deepens (OTCQB: EMETF)
Can RSA’s Microsoft partnership protect enterprise AI agents from the identity threats no one saw coming?
Arm Holdings launches first in-house data center CPU in historic company pivot targeting agentic AI infrastructure
Read More 8 minute read Pharma Industry News Gilead Sciences bets $2.2bn on immune reset with Ouro Medicines BCMAxCD3 bispecific acquisition Gilead Sciences agrees to acquire Ouro Medicines for up to $2.175bn, adding BCMA T cell engager gamgertamig to its inflammation pipeline. Read the full strategic analysis. byVenkateshMarch 24, 2026